DK2419087T3 - Medicinsk fusidinsyrecreme, som fremstilles under anvendelse af natriumfusidat og inkorporerer en biopolymer, samt fremgangsmåde til fremstilling deraf - Google Patents

Medicinsk fusidinsyrecreme, som fremstilles under anvendelse af natriumfusidat og inkorporerer en biopolymer, samt fremgangsmåde til fremstilling deraf

Info

Publication number
DK2419087T3
DK2419087T3 DK10718707.2T DK10718707T DK2419087T3 DK 2419087 T3 DK2419087 T3 DK 2419087T3 DK 10718707 T DK10718707 T DK 10718707T DK 2419087 T3 DK2419087 T3 DK 2419087T3
Authority
DK
Denmark
Prior art keywords
biopolymer
incorporates
medical
preparing
prepared
Prior art date
Application number
DK10718707.2T
Other languages
Danish (da)
English (en)
Inventor
Madhavan Srinivasan
Neelakandan Narayanan Chulliel
Kuppusamy Senthilkumar
Vanangamudi Subramaniam Sulur
Original Assignee
Vanangamudi Subramaniam Sulur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vanangamudi Subramaniam Sulur filed Critical Vanangamudi Subramaniam Sulur
Application granted granted Critical
Publication of DK2419087T3 publication Critical patent/DK2419087T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK10718707.2T 2009-04-13 2010-04-12 Medicinsk fusidinsyrecreme, som fremstilles under anvendelse af natriumfusidat og inkorporerer en biopolymer, samt fremgangsmåde til fremstilling deraf DK2419087T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN960MU2009 2009-04-13
PCT/IB2010/051552 WO2010119385A1 (en) 2009-04-13 2010-04-12 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and a process to make it

Publications (1)

Publication Number Publication Date
DK2419087T3 true DK2419087T3 (da) 2013-05-06

Family

ID=42558569

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10718707.2T DK2419087T3 (da) 2009-04-13 2010-04-12 Medicinsk fusidinsyrecreme, som fremstilles under anvendelse af natriumfusidat og inkorporerer en biopolymer, samt fremgangsmåde til fremstilling deraf

Country Status (19)

Country Link
US (1) US8895542B2 (zh)
EP (1) EP2419087B1 (zh)
JP (1) JP5205549B2 (zh)
KR (1) KR101642537B1 (zh)
CN (1) CN102159191B (zh)
BR (1) BRPI1006729B1 (zh)
CA (1) CA2795611C (zh)
CY (1) CY1113885T1 (zh)
DK (1) DK2419087T3 (zh)
ES (1) ES2404156T3 (zh)
HR (1) HRP20130149T1 (zh)
IL (1) IL215641A (zh)
MX (1) MX2011010784A (zh)
PL (1) PL2419087T3 (zh)
PT (1) PT2419087E (zh)
RU (1) RU2537023C2 (zh)
SI (1) SI2419087T1 (zh)
SM (1) SMT201300059B (zh)
WO (1) WO2010119385A1 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101457789B1 (ko) * 2013-02-13 2014-11-03 동아제약 주식회사 상처 치료용 필름형성 약제학적 조성물 및 그의 제조방법
CA2906663A1 (en) 2013-03-15 2014-09-18 Techulon Inc. Antisense molecules for treatment of staphylococcus aureus infection
WO2017091167A1 (en) 2015-11-28 2017-06-01 Pharmacti̇ve İlaç San. Ve Ti̇c. A.Ş. Topical pharmaceutical composition comprising fusidic acid, isoconazole, dexpanthenol and hydrocortisone
CN107224426A (zh) * 2017-07-08 2017-10-03 天津双硕医药科技有限公司 一种含有夫西地酸的外用乳膏组合物
CN111012747B (zh) * 2018-10-10 2022-11-25 四川海思科制药有限公司 一种注射用夫西地酸钠药物组合物及其制备方法
CN114432250B (zh) * 2022-02-22 2022-10-04 深圳市泰力生物医药有限公司 一种非晶态夫西地酸的稳定方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8500310D0 (en) * 1985-01-07 1985-02-13 Leo Pharm Prod Ltd Pharmaceutical preparation
SU1380751A2 (ru) * 1986-03-12 1988-03-15 Всесоюзный научно-исследовательский институт антибиотиков Средство дл лечени гнойно-воспалительных заболеваний кожи и м гких тканей
DK603988D0 (da) * 1988-10-28 1988-10-28 Klaus Bendtzen Farmaceutisk praeparat
TW460296B (en) * 1994-09-01 2001-10-21 Janssen Pharmaceutica Nv Topical ketoconazole emulsion compositions without sodium sulfite
CN1140266C (zh) * 1997-11-25 2004-03-03 山之内欧洲有限公司 二醇与α羟基酸的混合物在治疗角化过度性皮肤病中的用途
US20070265352A1 (en) * 2002-02-19 2007-11-15 Joachim Roeding Synergistic mixtures of at least one 1,2 alkanediol such as 1,2-hexanediol and 1,2-octanediol with a further compound having antimicrobial properties
ES2204331B1 (es) * 2002-10-09 2005-03-01 Ercros Industrial, S.A. Procedimiento para la obtencion de acido fusidico a partir de un caldo de fermentacion.
US20080206161A1 (en) 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
RU2240781C1 (ru) * 2003-06-05 2004-11-27 Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии Способ лечения воспалительных процессов вульвы и влагалища
WO2005090352A1 (en) * 2004-03-16 2005-09-29 Glaxo Group Limited Pyrazolo[3,4-b]pyridine compound, and its use as a pde4 inhibitor
KR20080090498A (ko) * 2006-02-02 2008-10-08 레오 파마 에이/에스 항균 물질을 포함하는 국소 조성물
US9132071B2 (en) * 2006-07-28 2015-09-15 Santen Sas Compositions containing quaternary ammonium compounds
US20080182819A1 (en) * 2007-01-29 2008-07-31 Act Iii Licensing, Llc Chitosan compositions and methods for using chitosan compositions in the treatment of health disorders
EP2373288B1 (en) * 2008-12-19 2015-04-08 Vanangamudi, Sulur Subramaniam A novel dermaceutical cream made using sodium fusidate
PL2403480T3 (pl) * 2009-02-18 2013-08-30 Sulur Subramaniam Vanangamudi Sposób wytwarzania kremu z kwasem fusydowym

Also Published As

Publication number Publication date
CY1113885T1 (el) 2016-07-27
HRP20130149T1 (hr) 2013-03-31
IL215641A (en) 2014-09-30
EP2419087A1 (en) 2012-02-22
WO2010119385A1 (en) 2010-10-21
SI2419087T1 (sl) 2013-06-28
ES2404156T3 (es) 2013-05-24
KR101642537B1 (ko) 2016-07-25
CN102159191B (zh) 2014-04-02
KR20120023653A (ko) 2012-03-13
MX2011010784A (es) 2012-01-12
RU2011146230A (ru) 2013-05-20
IL215641A0 (en) 2012-01-31
PL2419087T3 (pl) 2013-06-28
JP5205549B2 (ja) 2013-06-05
BRPI1006729A2 (pt) 2020-10-06
US8895542B2 (en) 2014-11-25
CN102159191A (zh) 2011-08-17
SMT201300059B (it) 2013-07-09
RU2537023C2 (ru) 2014-12-27
EP2419087B1 (en) 2013-01-23
PT2419087E (pt) 2013-04-26
CA2795611A1 (en) 2010-10-21
CA2795611C (en) 2016-09-20
JP2012523451A (ja) 2012-10-04
US20120040946A1 (en) 2012-02-16
BRPI1006729B1 (pt) 2021-10-05

Similar Documents

Publication Publication Date Title
DK3196309T3 (da) Thraustochytrider, fedtsyresammensætninger og fremgangsmåder til fremstilling og anvendelse deraf
BRPI1013822A2 (pt) Método para síntese de um trissacarídeo.
DK2381965T3 (da) Modulation af præ-mrna under anvendelse af splejsningsmodulerende oligonukleotider som terapeutiske midler til behandling af sygdom
DK2480658T3 (da) Fremgangsmåde til fremstilling af planteafledte vlp
BRPI1011936A2 (pt) métodos biológicos para a preparação de ácido adípico
BRPI0917617A2 (pt) Método para produzir açúcar líquido e método para produzir um produto químico
DK2213678T3 (da) Fremgangsmåde til fremstilling af opløst lignin, saccharidråmateriale og monosaccharidråmateriale såvel som opløst lignin
BRPI1005998A2 (pt) metodo para prover o suporte de pressao a um paciente, sistema de suporte de pressao e metodo para prover suporte de pressao a um paciente
DK2429486T3 (da) Fremgangsmåde til fremstilling af en tværbundet gel
BRPI0914494A2 (pt) conector de cartuchos médicos para conexão liberável a um cartucho médico, método de fabricação de um conector de cartuchos médicos e método de conexão liberável de um cartucho médico
DK2496562T3 (da) Fremgangsmåde til fremstilling af calcobutrol
EP2650384A4 (en) METHOD FOR PRODUCING AN AQUEOUS SUGAR SOLUTION
BR112012001998A2 (pt) solução oftálmica, uso de um composto, e, método para preparação de uma solução oftálmica.
BR112012022332A2 (pt) "método de produção de solução de açucar refinado aquosa e ,étodo de produção de um produto quimico"
BRPI0912403A2 (pt) pasta aquosa, concreto, e, métodos para preparar uma pasta aquosa e para preparar um concreto
DK2419087T3 (da) Medicinsk fusidinsyrecreme, som fremstilles under anvendelse af natriumfusidat og inkorporerer en biopolymer, samt fremgangsmåde til fremstilling deraf
DK2253218T3 (da) Fremgangsmåde og anlæg til bedøvelse af fjerkræ og fjerkræ, som herved er blevet tømt for blod
DK2513063T3 (da) Fremgangsmåde til fremstilling af 1-alkyl-/1-aryl-5-pyrazolcarboxylsyrederivater
BRPI0922173A2 (pt) preparação farmacêutica, e, método para preparar uma preparação farmacêutica
DK3378930T3 (da) Scaffold til vækst af væv in vivo
DK2350026T3 (da) Sulfoximinsubstituerede anilinopyrimidinderativer som cdk-inhibitorer, fremstilling og anvendelse heraf som lægemiddel
DK2920240T3 (da) Fremgangsmåde til fremstilling af en vandig opløsning af chitosan, chitosansammensætning, chitosanaerosol, fremgangsmåde til fremstilling af en chitosanhydrogelmembran og fremgangsmåde til fremstilling af et chitosan-protein-biopolymermateriale
DK2462098T3 (da) Fremgangsmåde til fremstillingen af derivater af 1-(2-halobiphenyl-4-yl)-cyclopropancarboxylsyre
DK2403364T3 (da) Fremgangsmåde til fremstilling af opløsninger af astaxanthin-derivater
BRPI1014436A2 (pt) composto, processo de preparação de um composto, intermediário, composições farmacêuticas, e, utilização de um composto.